David Liu

Prof. David Liu

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2013 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
DLDavid Liu
David Liu
EBElisabeth Banham
Elisabeth Banham
SYSrinivasa Yellapu
Srinivasa Yellapu

16 January 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RBRita A. Busuttil
Rita A. Busuttil
DLDavid Liu
David Liu
NCNatasha Di Costanzo
Natasha Di Costanzo
JSJan Schröder
Jan Schröder
CMCatherine Mitchell
Catherine Mitchell
ABAlex Boussioutas
Alex Boussioutas
Gastric cancer is a leading cause of cancer death worldwide, with advanced stage being correlated to the level of tumour invasion and metastasis. Current research is heavily focused on the identification and development of efficacious therapeutics targeting these fundamental hallmarks of cancer, however there are currently no animal models that mimic the invasive phenotypes observed in humans. To address this we have developed an orthotopic mouse model whereby gastric cancer cell lines are tagged with luciferase and injected into the subserosal layer of the stomach. This allows for the monitoring of primary tumour growth and metastasis in real-time as well as quantitation of the degree of tumour invasion through the stomach wall by immunohistochemistry. We have three models based on the degree of invasion and metastasis that are cell line specific: The AGS cells develop into invasive tumours by 4-weeks with no evidence of metastases, MKN45 cells are moderately metastatic with minimal invasion till week 2 and MKN28 cells are highly metastatic and fully invasive by week 1. These models have utility as a tool for testing the efficacy of anti-tumour, anti-invasive and anti-metastatic therapies in the setting of gastric cancer, which currently has poor treatment options.

30 June 2022 in Surgery
Verified
Journal Article
Closed access
ALAmar Lakhani
Amar Lakhani
WJWael Jamel
Wael Jamel
GRGeorgina E. Riddiough
Georgina E. Riddiough
CCCarlos S. Cabalag
Carlos S. Cabalag
SSSean Stevens
Sean Stevens
DLDavid Liu
David Liu

Verified
Journal Article
Open access
PDF file
AEAnn-Kathrin Eichelmann
Ann-Kathrin Eichelmann
GMGeorge Mayne
George Mayne
KCKaren Chiam
Karen Chiam
SDSteven L. Due
Steven L. Due
IBIsabell Bastian
Isabell Bastian
DHDamian J. Hussey
Damian J. Hussey
TP53 gene mutations occur in 70% of oesophageal adenocarcinomas (OACs). Given the central role of p53 in controlling cellular response to therapy we investigated the role of mutant (mut-) p53 and SLC7A11 in a CRISPR-mediated JH-EsoAd1 TP53 knockout model. Response to 2 Gy irradiation, cisplatin, 5-FU, 4-hydroxytamoxifen, and endoxifen was assessed, followed by a TaqMan OpenArray qPCR screening for differences in miRNA expression. Knockout of mut-p53 resulted in increased chemo- and radioresistance (2 Gy survival fraction: 38% vs. 56%, p < 0.0001) and in altered miRNA expression levels. Target mRNA pathways analyses indicated several potential mechanisms of treatment resistance. SLC7A11 knockdown restored radiosensitivity (2 Gy SF: 46% vs. 73%; p = 0.0239), possibly via enhanced sensitivity to oxidative stress. Pathway analysis of the mRNA targets of differentially expressed miRNAs indicated potential involvement in several pathways associated with apoptosis, ribosomes, and p53 signaling pathways. The data suggest that mut-p53 in JH-EsoAd1, despite being classified as non-functional, has some function related to radio- and chemoresistance. The results also highlight the important role of SLC7A11 in cancer metabolism and redox balance and the influence of p53 on these processes. Inhibition of the SLC7A11-glutathione axis may represent a promising approach to overcome resistance associated with mut-p53.

1 January 2021 in Journal of Surgical Research
Verified
Journal Article
Closed access
DLDavid Liu
David Liu
CCChao Cheng
Chao Cheng
RIRumana Islam
Rumana Islam
MTMark Tacey
Mark Tacey
ASAnkur Sidhu
Ankur Sidhu
NSNeil Strugnell
Neil Strugnell

9 June 2020 in Anz Journal of Surgery
Verified
Journal Article
Closed access
PDF file
DLDavid Liu
David Liu
SSSean Stevens
Sean Stevens
EWEnoch Wong
Enoch Wong
JFJonathan Fong
Jonathan Fong
KMKrinal Mori
Krinal Mori
TCthe VERITAS Collaborative
the VERITAS Collaborative